Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

vorasidenib (S95032)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Servier

Drug class:

IDH1 inhibitor, IDH2 inhibitor

Related drugs:

IDH2 mutation	Glioma	IDH2 mutation	Glioma	S95032 Sensitive: B - Late Trials S95032 Sensitive : B	S95032 Sensitive: B - Late Trials S95032 Sensitive : B
IDH1 mutation	Glioma	IDH1 mutation	Glioma	S95032 Sensitive: B - Late Trials S95032 Sensitive : B	S95032 Sensitive: B - Late Trials S95032 Sensitive : B
IDH2 mutation	Oligodendroglioma	IDH2 mutation	Oligodendroglioma	S95032 Sensitive: B - Late Trials S95032 Sensitive : B	S95032 Sensitive: B - Late Trials S95032 Sensitive : B
IDH2 mutation	Astrocytoma	IDH2 mutation	Astrocytoma	S95032 Sensitive: B - Late Trials S95032 Sensitive : B	S95032 Sensitive: B - Late Trials S95032 Sensitive : B
IDH1 mutation	Astrocytoma	IDH1 mutation	Astrocytoma	S95032 Sensitive: B - Late Trials S95032 Sensitive : B	S95032 Sensitive: B - Late Trials S95032 Sensitive : B
IDH1 mutation	Oligodendroglioma	IDH1 mutation	Oligodendroglioma	S95032 Sensitive: B - Late Trials S95032 Sensitive : B	S95032 Sensitive: B - Late Trials S95032 Sensitive : B